Scopus BioPharma Inc.
SCPS · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $2,067 | $28,294 | $198,306 | $88,656 |
| - Cash | $125 | $7,943 | $1,832 | $37 |
| + Debt | $0 | $0 | $2,284 | $0 |
| Enterprise Value | $1,943 | $20,351 | $198,758 | $88,619 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$11,713 | -$26,177 | -$10,154 | -$2,689 |
| % Margin | – | – | – | – |
| Net Income | -$11,610 | -$27,728 | -$11,569 | -$2,690 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.55 | -1.61 | -0.87 | -0.18 |
| % Growth | 65.8% | -85.1% | -383.3% | – |
| Operating Cash Flow | -$8,127 | -$11,425 | -$2,525 | -$2,120 |
| Capital Expenditures | -$2 | -$2 | $0 | -$4 |
| Free Cash Flow | -$8,128 | -$11,427 | -$2,525 | -$2,125 |